Press Release: $1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics
Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Biopharmaceutical CXO Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Biopharmaceutical CXO Market grew from USD 655.12 million in 2025 to USD 706.90 million in 2026. It is expected to continue growing at a CAGR of 7.04%, reaching USD 1.05 billion by…
SANTA CLARA, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice and conversational AI, today announced a strategic partnership with Associated Carrier Group (ACG), a member-driven organization representing Tier 2 and Tier 3 mobile network operators and resellers. The partnership comes as the telecommunications industry moves to…
9 April 2026, Frankfurt - Bitwise today announces the launch of the Bitwise Hyperliquid Staking ETP (Ticker BHYP; ISIN DE000A4ARTJ5) on Deutsche Börse Xetra. The product seeks to provide exchange-traded exposure to HYPE, the native token of the Hyperliquid network, tracking the Kaiko HYPE Reference Rate LDNLF index. In addition to price exposure, the ETP…
PORTOLA VALLEY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a national nonprofit and leading sponsor of tick-borne disease research in the US, today announced publication of a new peer-reviewed article in Frontiers in Medicine examining the transmission of the Lyme bacteria during pregnancy. The publication points to observational research demonstrating that Lyme…
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Paloma Acquisition Corp I (Nasdaq: PALOU) (the “Company”) today announced that, commencing on April 13, 2026, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”)…
